Deep-pocketed investors have adopted a bearish approach towards Bausch Health Companies BHC, and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in BHC usually suggests something big is about to happen.
We gleaned this information from our observations today when Benzinga's options scanner highlighted 8 extraordinary options activities for Bausch Health Companies. This level of activity is out of the ordinary.
The general mood among these heavyweight investors is divided, with 25% leaning bullish and 75% bearish. Among these notable options, 2 are puts, totaling $68,905, and 6 are calls, amounting to $840,886.
Expected Price Movements
Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $5.0 to $8.0 for Bausch Health Companies over the last 3 months.
Insights into Volume & Open Interest
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Bausch Health Companies's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Bausch Health Companies's whale activity within a strike price range from $5.0 to $8.0 in the last 30 days.
Bausch Health Companies 30-Day Option Volume & Interest Snapshot
Biggest Options Spotted:
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|
| BHC | CALL | TRADE | BEARISH | 06/21/24 | $6.00 | $474.0K | 1 | 0 |
| BHC | CALL | TRADE | BEARISH | 01/19/24 | $8.00 | $133.8K | 3.5K | 225 |
| BHC | CALL | TRADE | BEARISH | 01/19/24 | $8.00 | $112.0K | 3.5K | 10.0K |
| BHC | CALL | TRADE | BEARISH | 01/19/24 | $8.00 | $50.8K | 3.5K | 15.0K |
| BHC | CALL | SWEEP | BULLISH | 12/22/23 | $6.50 | $40.7K | 21 | 757 |
About Bausch Health Companies
Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.
Present Market Standing of Bausch Health Companies
- Currently trading with a volume of 2,051,244, the BHC's price is up by 0.69%, now at $7.3.
- RSI readings suggest the stock is currently may be approaching overbought.
- Anticipated earnings release is in 63 days.
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Bausch Health Companies options trades with real-time alerts from Benzinga Pro.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Date of Trade | ticker | Put/Call | Strike Price | DTE | Sentiment |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
